Our progress to date includes: We redesigned preprocessing workflows and reduced preparation time from approximately 9 hours to ~2 hours in our current development system. Selective Recovery Validation We demonstrated early-stage structure-dependent recovery of higher-integrity collagen fractions. Characterization studies completed for collagen I (FTIR + Control Assays + CD Spec) Rheological studies begin shortly. Purification Infrastructure: We built a tangential flow filtra

Today, if one suffers a severe burn or a chronic wound, the speed at which they heal is dictated by their wallet. The best regenerative treatments are made from expensive, imported materials, forcing doctors to use slow, basic bandages for most patients. That means healing is available, just not accessible till the last person standing. Many advance systems that create skin grafts, tissue models, healing patches utilize structurally sensitive material inputs that are derived

Some of the most ambitious ideas in healthcare, engineered tissues, regenerative medicine, advanced wound healing, realistic cell models, 3D bioprinting, depend on one quiet ingredient: reliable biomaterials. And one of the most important of those materials is Type I collagen. Collagen is the structural protein that gives tissues strength and architecture. It is widely used in scaffolds, hydrogels, wound matrices, bioinks, and research systems. In many ways, collagen is not t

Collagen is a crucial protein that plays a significant role in the structure and function of various tissues in the body. It is the most abundant protein in mammals, making up about 30% of the total protein content. As the demand for biomaterials continues to grow, the need for innovative methods of collagen production has become increasingly important. This blog post explores the latest advancements in collagen production, focusing on how these innovations are revolutionizin

In the ever-evolving landscape of biotechnology, I find that few companies stand out as beacons of innovation and reliability. Tvashtr Biotech is one such company, and I am proud to be part of a team dedicated to advancing the field of structural proteins. With a commitment to quality and consistency, I believe that Tvashtr Biotech is not just a participant in the industry; we are pioneers, setting new standards for what can be achieved in protein production and application.